Biohub's Rare As One Network Opens $150M Funding Round

Biohub, funded by Chan Zuckerberg Initiative, announced it will open a new funding round for its Rare As One Network this fall. This will be the fourth round, with over $150 million committed to rare disease initiatives in total. The focus will be on rare pulmonary and immune diseases, as well as rare cancers. Additionally, Biohub is expanding its partnership with Every Cure to leverage AI for drug repurposing, aiming to enhance patient-centric research programs.